Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Dry eye treatment devices industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Technology trends
2.5 End-use trends
Chapter 3 Dry Eye Treatment Devices Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of dry eye disease
3.2.1.2 Growing usage of visual display terminals
3.2.1.3 Rising demand for dry eye treatment technology in ophthalmic centers
3.2.1.4 Increasing number of contact lens wearers
3.2.2 Industry pitfalls & challenges
3.2.2.1 Presence of contraindication pertaining to intense pulsed light
3.2.2.2 Availability of alternative treatment options
3.3 Growth potential analysis
3.3.1 By technology
3.3.2 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Key market trends
3.7 Reimbursement scenario
3.8 Technology landscape
3.9 Future market trends
3.10 Value chain analysis
3.11 Gap Analysis
3.12 Porter's analysis
3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Vendor matrix analysis
4.5 Competitive positioning matrix
4.6 Strategy dashboard, 2022
Chapter 5 Dry Eye Treatment Devices Market Size and Forecast, By Technology (USD Million)
5.1 Key trends, by technology
5.2 Broadband light (BBL)
5.3 Intense pulsed light (IPL)
5.4 Meibomian gland expression (MGX)
5.5 Combination (MGX+IPL)
Chapter 6 Dry Eye Treatment Devices Market Size and Forecast, By End-use (USD Million)
6.1 Key trends, by end-use
6.2 Hospitals
6.3 Ophthalmic Clinics
6.4 Others
Chapter 7 Dry Eye Treatment Devices Market Size and Forecast, By Region (USD Million)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Sweden
7.3.7 Poland
7.3.8 The Netherlands
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Indonesia
7.4.7 Thailand
7.4.8 Philippines
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Colombia
7.5.5 Chile
7.5.6 Peru
7.6 MEA
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Israel
7.6.5 Egypt
7.6.6 Turkey
Chapter 8 Company Profiles
8.1 Alcon
8.2 Allergan (AbbVie)
8.3 BioTissue, Inc
8.4 BlephEx LLC
8.5 ESW Vision
8.6 EyePrint Prosthetics, LLC
8.7 Holbar Medical Products
8.8 Johnson & Johnson Vision
8.9 Lumenis
8.10 Mibo Medical Group
8.11 NuSight Medical
8.12 Sight Sciences
